secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2021-08-23T23:59:59+00:00
Accession:  0001493152-21-020997
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pure Bioscience appoints Ivan Chen as Board Chair, replacing Tom Lee
--------------------------------------------------------------------

- Ivan Chen, current non-employee director, appointed Board Chair effective August 19, 2021.
- Tom Lee steps down as Chair but remains President and Chief Executive Officer.
- No other changes to the Board or management.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315221020997/0001493152-21-020997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315221020997/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-020997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer